Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,061 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of empagliflozin on estimated extracellular volume, estimated plasma volume, and measured glomerular filtration rate in patients with heart failure (Empire HF Renal): a prespecified substudy of a double-blind, randomised, placebo-controlled trial.
Jensen J, Omar M, Kistorp C, Tuxen C, Gustafsson I, Køber L, Gustafsson F, Faber J, Malik ME, Fosbøl EL, Bruun NE, Forman JL, Jensen LT, Møller JE, Schou M. Jensen J, et al. Among authors: malik me. Lancet Diabetes Endocrinol. 2021 Feb;9(2):106-116. doi: 10.1016/S2213-8587(20)30382-X. Epub 2020 Dec 22. Lancet Diabetes Endocrinol. 2021. PMID: 33357505 Clinical Trial.
Impact of socioeconomic position on initiation of SGLT-2 inhibitors or GLP-1 receptor agonists in patients with type 2 diabetes - a Danish nationwide observational study.
Falkentoft AC, Andersen J, Malik ME, Selmer C, Gæde PH, Staehr PB, Hlatky MA, Fosbøl E, Køber L, Torp-Pedersen C, Gislason GH, Gerds TA, Schou M, Bruun NE, Ruwald AC. Falkentoft AC, et al. Among authors: malik me. Lancet Reg Health Eur. 2022 Jan 25;14:100308. doi: 10.1016/j.lanepe.2022.100308. eCollection 2022 Mar. Lancet Reg Health Eur. 2022. PMID: 35146474 Free PMC article.
Discontinuation and reinitiation of SGLT-2 inhibitors and GLP-1R agonists in patients with type 2 diabetes: a nationwide study from 2013 to 2021.
Malik ME, Falkentoft AC, Jensen J, Zahir D, Parveen S, Alhakak A, Andersson C, Petrie MC, Sattar N, McMurray JJV, Køber L, Schou M. Malik ME, et al. Lancet Reg Health Eur. 2023 Mar 17;29:100617. doi: 10.1016/j.lanepe.2023.100617. eCollection 2023 Jun. Lancet Reg Health Eur. 2023. PMID: 37265783 Free PMC article.
3,061 results